Similarly, high expression of the cathepsin family of proteases (CTSC, CTSZ, CTSB) was found to be indicative of poor prognosis in breast cancer patients but appeared to have no significant predictive value in prostate cancer patients. Here, CTSB is linked to prostate carcinoma.